See Wegovy and MACE risk reduction data Getting your patients started MACE, major adverse cardiovascular events
Safety and Precautions While BPC 157 is generally considered safe with low toxicity, its still recommended to: Store the peptide at 28C (refrigerated) after reconstitution Use sterile water for mixing Avoid use if pregnant, nursing, or dealing with underlying conditions without medical clearance Mild injection site irritation may occur, but side effects are rare when used properly.
A meta-analysis of over 80,000 patients reported 16: 16% reduction in kidney failure risk 18% reduction in worsening kidney function These benefits are thought to be largely driven by improvements in: Blood sugar control Blood pressure Body weight and inflammation Fertility and Reproductive Function GLP-1 therapies have also been linked to improvements in fertility outcomes, particularly in individuals with obesity or insulin resistance
A key 6-year follow-up study (N=266, elderly patients aged 60-89) published in Bulletin of Experimental Biology and Medicine demonstrated that Epithalamin treatment normalized melatonin production, improved T-cell immunity markers (CD3+, CD4+, CD4/CD8 ratio), and reduced cardiovascular mortality by 28% compared to the control group
Your doctor consultation ensures your progress is regularly monitored, your treatment stays safe, and any adjustments needed over time are guided by medical expertise
Glucagon-like peptide 1 conjugated to recombinant human serum albumin variants with modified neonatal Fc receptor binding properties